Blue Crest Capital Management LTD Quest Diagnostics Inc Transaction History

Blue Crest Capital Management LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$79.75 - $108.38 $444,526 - $604,110	-5,574 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$105.42 - $114.99 $2.86 Million - $3.12 Million	-27,144 Reduced 82.96%	5,574 $601,000
Q2 2018 Aug 14, 2018	BUY	$97.35 - $113.14 $2.68 Million - $3.11 Million	27,525 Added 530.04%	32,718 $3.6 Million
Q1 2018 May 15, 2018	SELL	$96.42 - $107.88 $513,918 - $575,000	-5,330 Reduced 50.65%	5,193 $521,000
Q4 2017 Feb 14, 2018	BUY	$90.86 - $100.24 $956,119 - $1.05 Million	10,523	10,523 $1.04 Million

925

95.1M

379K

354K

Ticker DGX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 113,887,000
Market Cap $15.6B
Description
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Blue Crest Capital Management LTD with notifications on news.